- Home
- BLCO
as of 03-09-2026 3:40pm EST
$17.05
$0.04
-0.26%
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
| Founded: | 1853 | Country: | Canada |
| Employees: | N/A | City: | VAUGHAN |
| Market Cap: | 6.0B | IPO Year: | 2022 |
| Target Price: | $18.55 | AVG Volume (30 days): | 454.5K |
| Analyst Decision: | Buy | Number of Analysts: | 12 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.02 | EPS Growth: | -13.33 |
| 52 Week Low/High: | $10.45 - $18.91 | Next Earning Date: | 05-21-2026 |
| Revenue: | $5,101,000,000 | Revenue Growth: | 6.47% |
| Revenue Growth (this year): | 8.61% | Revenue Growth (next year): | 5.52% |
| P/E Ratio: | -16.75 | Index: | N/A |
| Free Cash Flow: | -66000000.0 | FCF Growth: | N/A |
Stock Insider Trading Activity of Bausch + Lomb Corporation (BLCO)
Ross Thomas W. Sr.
Buy
Director
BLCO Mar 3, 2026
Avg Cost/Share
$17.68
Shares
4,500
Total Value
$79,555.50
Owned After
64,891
SEC Form 4
Alfonso Eduardo
Buy
Director
BLCO Mar 2, 2026
Avg Cost/Share
$17.90
Shares
4,300
Total Value
$76,970.00
Owned After
9,555
SEC Form 4
VON ESCHENBACH ANDREW C.
Buy
Director
BLCO Feb 27, 2026
Avg Cost/Share
$18.31
Shares
4,364
Total Value
$79,883.02
Owned After
66,450
SEC Form 4
COLLIS STEVEN H
Buy
Director
BLCO Feb 23, 2026
Avg Cost/Share
$17.81
Shares
15,000
Total Value
$267,150.00
Owned After
20,255
SEC Form 4
ROBERTSON RUSSEL C
Buy
Director
BLCO Feb 20, 2026
Avg Cost/Share
$17.90
Shares
4,400
Total Value
$78,760.00
Owned After
72,407
SEC Form 4
Ling Karen
Buy
Director
BLCO Feb 19, 2026
Avg Cost/Share
$17.74
Shares
4,000
Total Value
$70,968.00
Owned After
41,676
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Ross Thomas W. Sr. | BLCO | Director | Mar 3, 2026 | Buy | $17.68 | 4,500 | $79,555.50 | 64,891 | |
| Alfonso Eduardo | BLCO | Director | Mar 2, 2026 | Buy | $17.90 | 4,300 | $76,970.00 | 9,555 | |
| VON ESCHENBACH ANDREW C. | BLCO | Director | Feb 27, 2026 | Buy | $18.31 | 4,364 | $79,883.02 | 66,450 | |
| COLLIS STEVEN H | BLCO | Director | Feb 23, 2026 | Buy | $17.81 | 15,000 | $267,150.00 | 20,255 | |
| ROBERTSON RUSSEL C | BLCO | Director | Feb 20, 2026 | Buy | $17.90 | 4,400 | $78,760.00 | 72,407 | |
| Ling Karen | BLCO | Director | Feb 19, 2026 | Buy | $17.74 | 4,000 | $70,968.00 | 41,676 |
Earnings Transcripts
SEC 8-K filings with transcript text
2025 Q4 Q4 2025 Earnings
8-K BUY Feb 18, 2026 · 100% conf.
2025
Q4
Q4 2025 Earnings
8-K BUYFeb 18, 2026 · 100% conf.
AI Prediction BUY
1D
+0.09%
$17.69
5D
+2.83%
$18.17
20D
+2.37%
$18.09
Price: $17.67 Prob +5D: 100% AUC: 1.000
0001860742-26-000006
blco-202602180001860742FALSEBausch & Lomb Corp00018607422026-02-182026-02-18
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 18, 2026 Date of Report (Date of the earliest event reported)
Bausch + Lomb Corporation (Exact Name of Registrant as Specified in Its Charter)
Canada 001-41380 98-1613662
(State or Other Jurisdiction of Incorporation or Organization) (Commission File Number) (I.R.S. Employer Identification Number)
520 Applewood Crescent Vaughan, Ontario Canada L4K 4B4 (Address of Principal Executive Offices)(Zip Code) (905) 695-7700 (Registrant’s telephone number, including area code) N/A (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Shares, No Par Value
BLCO
New York Stock Exchange Toronto Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition. On February 18, 2026, Bausch + Lomb Corporation (the “Company”) issued a press release announcing results of operations for the quarter and the year ended December 31, 2025 and certain other financial information as of and for the quarter and the year ended December 31, 2025. A copy of the press release is attached as Exhibit 99.1 to this report and is incorporated herein by this reference. The information in this Item 2.02, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Item 2.02 and Exhibit 99.1 shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended. Item 9.01. Financial Statements and Exhibits. (d) Exhibits
Exhibit No.Description 99.1* Press Release of Bausch + Lomb Corporation, respecting financial results for the fourth quarter and full year ended December 31, 2025, dated February 18, 2026
104*Cover Page Interactive Data File (formatted as Inline XBRL)
* Filed herewith.
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
BAUSCH + LOMB CORPORATION
By:/s/ Sam Eldessouky
Name:Sam Eldessouky Title:Executive Vice President, Chief Financial Officer
Date: February 18, 2026
2025 Q3 Q3 2025 Earnings
8-K Oct 29, 2025
2025
Q3
Q3 2025 Earnings
8-KOct 29, 2025
0001860742-25-000021
blco-202510290001860742FALSEBausch & Lomb Corp00018607422025-10-292025-10-29
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 October 29, 2025 Date of Report (Date of the earliest event reported)
Bausch + Lomb Corporation (Exact Name of Registrant as Specified in Its Charter)
Canada 001-41380 98-1613662
(State or Other Jurisdiction of Incorporation or Organization) (Commission File Number) (I.R.S. Employer Identification Number)
520 Applewood Crescent Vaughan, Ontario Canada L4K 4B4 (Address of Principal Executive Offices)(Zip Code) (905) 695-7700 (Registrant’s telephone number, including area code) N/A (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Shares, No Par Value
BLCO
New York Stock Exchange Toronto Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition. On October 29, 2025, Bausch + Lomb Corporation (the “Company”) issued a press release announcing results of operations for the quarter ended September 30, 2025 and certain other financial information as of and for the quarter ended September 30, 2025. A copy of the press release is attached as Exhibit 99.1 to this report and is incorporated herein by this reference. The information in this Item 2.02, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Item 2.02 and Exhibit 99.1 shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended. Item 9.01. Financial Statements and Exhibits. (d) Exhibits
Exhibit No.Description 99.1* Press Release of Bausch + Lomb Corporation, respecting financial results for the third quarter of 2025, dated October 29, 2025
104*Cover Page Interactive Data File (formatted as Inline XBRL)
* Filed herewith.
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
BAUSCH + LOMB CORPORATION
By:/s/ Sam Eldessouky
Name:Sam Eldessouky Title:Executive Vice President, Chief Financial Officer
Date: October 29, 2025
2025 Q2 Q2 2025 Earnings
8-K Jul 30, 2025
2025
Q2
Q2 2025 Earnings
8-KJul 30, 2025
0001860742-25-000016
blco-202507300001860742FALSEBausch & Lomb Corp00018607422025-07-302025-07-30
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 July 30, 2025 Date of Report (Date of the earliest event reported)
Bausch + Lomb Corporation (Exact Name of Registrant as Specified in Its Charter)
Canada 001-41380 98-1613662
(State or Other Jurisdiction of Incorporation or Organization) (Commission File Number) (I.R.S. Employer Identification Number)
520 Applewood Crescent Vaughan, Ontario Canada L4K 4B4 (Address of Principal Executive Offices)(Zip Code) (905) 695-7700 (Registrant’s telephone number, including area code) N/A (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Shares, No Par Value
BLCO
New York Stock Exchange Toronto Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition. On July 30, 2025, Bausch + Lomb Corporation (the “Company”) issued a press release announcing results of operations for the quarter ended June 30, 2025 and certain other financial information as of and for the quarter ended June 30, 2025. A copy of the press release is attached as Exhibit 99.1 to this report and is incorporated herein by this reference. The information in this Item 2.02, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Item 2.02 and Exhibit 99.1 shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended. Item 9.01. Financial Statements and Exhibits. (d) Exhibits
Exhibit No.Description 99.1* Press Release of Bausch + Lomb Corporation, respecting financial results for the second quarter of 2025, dated July 30, 2025
104*Cover Page Interactive Data File (formatted as Inline XBRL)
* Filed herewith.
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
BAUSCH + LOMB CORPORATION
By:/s/ Sam Eldessouky
Name:Sam Eldessouky Title:Executive Vice President, Chief Financial Officer
Date: July 30, 2025
Latest Bausch + Lomb Corporation News
BLCO Breaking Stock News: Dive into BLCO Ticker-Specific Updates for Smart Investing
Compare BLCO vs Leading Stocks
See how BLCO stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "BLCO Bausch + Lomb Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.